NEUROSCIENCE RESEARCH DAY
CAREER TALKS:
Applying your knowledge in industry
Graeme Moffat, PhD
Graeme is a co-founder and scientist with System2 Neurotechnology. Previously he worked as Chief Scientist and VP of Regulatory Affairs at Interaxon (Muse), as Chief Scientist with Meta (now Chan-Zuckerberg Meta), and as Managing Editor of Frontiers in Neuroscience as it grew to become the largest open access scholarly journal series in the field of neuroscience. His PhD in auditory cortical plasticity was supported by Oticon Medical (formerly Neurelec). Graeme is a Senior Fellow at the Munk School of Global Affairs and Public Policy (at the University of Toronto), a member of the board of the Ontario Centre of Innovation, and an advisor to the OECD’s neurotechnology policy initiative.
Anna Parachikova, PhD
Anna (Ani) earned her PhD in 2007 from the University of California, Irvine focusing on novel therapeutic opportunities within Alzheimer’s disease. Since then, she has worked in small biotechnology and larger pharmaceutical companies within research thereupon moving into medical affairs and business. Currently Ani is leading the launch readiness for rare diseases across six countries at UCB. Ani is curious, passionate, and focused on unlocking innovation and creating true patient value.
Rohit Kalvapalle, MSc
Rohit got his MSc. (Pharmacy & Pharmaceutical Sciences) from the University of Alberta in 2009. He tried to get into the Pharma Industry at that time and could not catch a break, so he took a detour from science and worked at Labatt Breweries in Edmonton for just over 2 years: first in the Brewery (Quality Control), and then in Sales. He finally broke into the Pharmaceutical Industry as a Medical Sales Representative in 2012, and eventually worked his way into his current role as a Medical Science Liaison (Neurology) with Eisai Canada in 2018. Rohit moved from Edmonton, AB to Paris, ON in 2019, and is responsible for providing physicians in Western Ontario with scientific education and resources related to the treatment of patients suffering from diseases like epilepsy and insomnia.